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Introduction
Parasitic infections are endemic to most tropical 
and subtropical regions of developing countries (WHO 
1997). Entamoeba histolytica, a protozoan parasite 
that inhabits the human gastrointestinal tract, causes 
asymptomatic infections in about 90% of infected peo-
ple playing a significant role in spreading the parasite. 
Prolonged asymptomatic infection can lead to invasive 
amoebiasis, whose symptoms may include bloody diar-
rhea, abdominal pain, flatulence, nausea, and vomiting. 
In some cases, the amebae may spread from the gas-
trointestinal tract to the liver and cause the formation 
of ulcerations and abscesses, resulting in amoebic liver 
abscesses (Haque et al. 2003).
Entamoeba dispar and Entamoeba moshkovskii are 
nonpathogenic intestinal protozoa that are morphologi-
cally identical to E. histolytica but are genetically and 
biochemically different (Clark and Diamond 1991; 
Diamond and Clark 1993). Previous studies showed 
that the infection rate of E. dispar in developed coun-
tries is much higher than E. histolytica (Pillai et al. 1999; 
Fotedar et al. 2007b). High levels of E. moshkovskii 
infection were reported on the Indian subcontinent. 
However, fewer studies have been conducted into the 
prevalence of this species. Human isolates have been 
reported in South Africa, North America, Italy, and 
Bangladesh (Ali 2003; Singh et al. 2009).
Amoebiasis develops in 50 million individuals glob-
ally, with an annual mortality rate of 40,000 to 100,000 
(WHO 1997). This high infection rate is likely inflated 
as a  result of false positives caused by the morpho-
logically indistinguishable, nonpathogenic E. dispar/
moshkovskii, and/or polymorphic nuclear leukocytes 
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A b s t r a c t
The present study was conducted to evaluate the infection rates of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii 
among asymptomatic individuals in Erbil City, northern Iraq. The research intent was to discover whether pathogenic or nonpathogenic 
species cause a high rate of symptomless Entamoeba infections. Stool samples were microscopically examined, and the 18S-rRNA gene 
was targeted utilizing the nested PCR technique in the positive specimens. Initial results based on morphological features showed that the 
Entamoeba prevalence rate was 7.4%. Significantly higher rates of infections were seen in females than in males and in low-income people 
than in moderate-income people. The incidence rates among the asymptomatic individuals, as determined by molecular analysis, were 
as follows: E. histolytica – 6%, E. dispar – 4.3%, and E. moshkovskii – 0.3%. Of all the Entamoeba positive samples, a single infection with 
E. histolytica was identified in 41.4% samples; the single infection with E. dispar in 18.6% samples, 35.7% samples had mixed infections 
with two Entamoeba species, and 4.3% had mixed infections with three species. The current study concluded that 7.4% of healthy people, 
who live in the endemic area under investigation, carry Entamoeba species asymptomatically. Additionally, the majority of asympto- 
matic Entamoeba infections were caused by the pathogenic E. histolytica (81.4%) compared to E. dispar (58.6%), and E. moshkovskii with 
the lowest rate of infection. Single and co-infections with E. histolytica and E. dispar were noted. E. moshkovskii, which was identified 
for the first time in the region, was only seen in mixed infections.
K e y  w o r d s: Entamoeba histolytica, Entamoeba dispar, Entamoeba moshkovskii, epidemiology, asymptomatic infections
Mahmood S.A.F. and Bakr H.M. 3264
and macrophages with similar morphology in the stool 
samples (Walsh 1986; Tanyuksel and Petri 2003). New 
methods have been developed that are better in dis-
tinguishing between the pathogenic E. histolytica and 
nonpathogenic amoebae in the stool sample. Emerg-
ing molecular-based techniques, such as polymerase 
chain reaction (PCR), have improved test specificity, 
or true positive rate of the target E. histolytica DNA 
(Tanyuksel and Petri 2003; Paul et al. 2007). Therefore, 
the most-recent epidemiological studies of E. histolytica 
use molecular methods to provide accurate data (Santos 
et al. 2010). To date, the PCR technique has never been 
used for assessing the prevalence rate of E. histolytica 
in Erbil City. Several studies have reported the infec-
tions with E. histolytica in almost all Iraqi cities, but 
only a few applied molecular methods; most relied on 
microscopic examination (Hamad and Ahmed 2011; 
Al-Sorchee et al. 2013; Saqur et al. 2017). To date, 
no research has been conducted on asymptomatic 
individuals in Iraq, the least-studied group globally. 
Moreover, it is mostly unknown whether the asympto-
matic individuals have been infected with E. histolytica 
or the nonpathogenic E. dispar and/or E. moshkovskii. 
This study was conducted to fill this gap in research and 
strives to determine the prevalence rate of Entamoeba 
in Erbil City, first using microscopic examination 
and then molecular techniques, to confirm the pres-




A total of 950 random stool samples (524 male and 
426 female) were collected from asymptomatic healthy 
adults in a cross-sectional study. The Central Laboratory 
of Erbil Province provided specimens from asympto-
matic individuals. Specimen donors filled out a struc-
tured questionnaire about personal status, residency, 
and source of water supply. The collected fresh stool 
samples were microscopically examined using the iodine 
and saline wet mount microscopy to detect Entamoeba 
trophozoites and/or cysts. About 0.2 g of each specimen 
was preserved at –80°C for molecular analysis.
DNA was extracted from specimens using the 
QiaAmp Fast DNA Stool Mini Kit (Qiagen, Hilden, 
Germany) following the manufacturer protocol. Finally, 
the purified DNA concentrate was eluted from the 
silica membrane spin column with a low salt buffer. 
DNA concentration was measured with a nanospectro-
photometer; then, each sample was labeled and stored 
at –20°C. A nested PCR was performed. The first PCR 
targeted the Entamoeba genus by amplifying the 897 bp 
of the 18S rRNA gene, while the second PCR primers 
targeted E. histolytica, E. dispar, and E. moshkovskii by 
amplifying the 439 bp, 174 bp, and 553 bp respectively. 
This method was previously described by Khairnar and 
Parija (2007). The primers targeting the 18S-ribosomal 
RNA gene were confirmed for specificity by the Basal 
Local Alignment Search Tool (BLAST), the genome 
database of all organisms from the National Center 
for Biotechnology Information (NCBI). PCR amplifi-
cation was performed using a thermal cycler (Techne 
Ltd., Cambridge, UK) with 20 µl reaction volumes that 
consisted of 10 µl Hot Start Master Mix (containing 
Taq DNA polymerase 1 unit/10 µl, 2 × reaction buffer, 
enzyme stabilizer, 4 mM MgCl2, sediment, 0.5 mM each 
of dATP, dCTP, dGTP, dTTP, pH 9, and loading dye) 
(GeNet Bio, Daejeon, South Korea); 2 µl of both the 
forward and reverse primers (10 ρmole for each), 2 µl of 
DNA template, and 6 µl of water. The PCR cycling and 
running parameters were defined as one cycle of initial 
denaturation at 95°C for 10 min followed by 30 cycles 
of 94°C for 30 sec, 58°C for 30 sec, and 72°C for 30 sec 
with a final extension of 72°C for 5 min. The second 
PCR used the same cycling and running parameters 
except that the first step used 35 cycles, and the anneal-
ing temperature changed to 52°C. Negative and positive 
controls were used in both PCR rounds. Positive control 
DNA for E. histolytica HM-1:IMSS, E. dispar SAW760, 
and Laredo strains of E. moshkovskii were obtained 
from Kurdistan Biomedical Science University, San-
andaj, Iran. The PCR products were electrophoresed 
in 1%, 1.5%, and 2% agarose gels with a 1X Tris-boric 
acid-EDTA buffer (TBE) and stained with 0.2 mg/ml of 
ethidium bromide (Sigma-Aldrich, St. Louis, Missouri, 
USA), with a 100-bp DNA marker ladder (Promega 
Corp., Madison, Wisconsin, USA).
Sequencing of PCR products. A single sample of 
each species was randomly selected and sequenced with 
species-specific primers in both forward and reverse 
directions using BigDye terminators and an ABI 3730XL 
sequencer (Macrogen® Corp., Seoul, South Korea). The 
nucleotide sequences of forward and reverse reactions 
were manually edited, and the sequences for each iden-
tified species were submitted to the GenBank.
Statistical analysis. The data was analyzed using the 
IBM SPSS Statistics Server Version 23. Results expressed 
using descriptive statistics: frequencies, percentages, 
Fisher exact test, and chi-square. P  value < 0.05 was 
regarded as statically significant.
Results
Sociodemographic factors associated with Enta-
moeba infection. Our simple random sample consisted 
of 55.2% male and 44.8% female individuals (Table I). 
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As determined by the microscopic examination, 7.4%, 
or 70 out of 950 stool samples from asymptomatic indi-
viduals, tested positive for Entamoeba species cysts and/
or characteristic features of the trophozoite. Quadrinu-
cleated spherical cysts and amoebic trophozoites with 
multiple pseudopodia of Entamoeba were observed 
using light microscopy and identified based on their 
morphology. A significantly higher (p < 0.05) rate of 
Gender
Male 524 (55.2%) 29 (41.4%) 524 (5.5%) 0.036  0.075 0.018*
Female 426 (44.8%) 41 (58.6%) 426 (9.6%) 0.069  0.125
Residency
Urban 702 (73.9%) 48 (68.6%) 702 (6.8%) 0.049  0.090 0.322
Rural 248 (26.1%) 22 (31.4%) 248 (8.9%) 0.054  0.125
Age group
15–18 87 (9.2%) 4 (5.7%) 87 (4.6%) 0.009  0.090
19–25 311 (32.7%) 24 (34.3%) 311 (7.7%) 0.048  0.108
26–35 328 (34.5%) 26 (37.1%) 328 (7.9%) 0.050  0.110 0.76
36–45 157 (16.5%) 13 (18.6%) 157 (8.3%) 0.00  0.100
> 45 67 (7.1%) 3 (4.3%) 67 (4.5%) 0.00  0.308
Educational level
Primary school 298 (31.4%) 25 (35.7%) 298 (8.4%) 0.053  0.115 
Secondary and high school 448 (47.2%) 31 (44.3%) 448 (6.9%) 0.044  0.096 0.73
Bachelor 204 (21.5%) 14 (20%) 204 (6.9%) 0.036  0.107 
Family size
1–2 92 (9.7%) 5 (7.1%) 92 (5.4%) 0.011  0.105
3–4 228 (24%) 13 (18.6%) 228 (5.7%) 0.028  0.086 0.563
5–6 301 (31.7%) 24 (34.3%) 301 (8%) 0.050  0.112
> 6 329 (34.6%) 28 (40%) 329 (8.5%) 0.055  0.116
Income status
Poor 355 (37.4%) 39 (55.7%) 355 (11%) 0.078  0.142
Middle class 594 (62.5%) 31 (44.3%) 594 (5.2%) 0.033  0.069 0.004*
Wealthy 1 (0.1%) 0 (0%) 1 (0%) 0.00  0.00
Source of water supply
Chlorinated water 646 (68%) 39 (55.7%) 646 (6%) 0.042  0.079
Well water 302 (31.8%) 31 (44.3%) 302 (10.3%) 0.068  0.138 0.062
Others 2 (0.2%) 0 (0%) 2 (0%) 0.00  0.00
Eating out of home
Never 259 (27.3%) 17 (24.3%) 259 (6.6%) 0.039  0.096
Sometimes 310 (32.6%) 24 (34.3%) 310 (7.7%) 0.045  0.110 0.857
Always 381 (40.1%) 29 (41.4%) 381 (7.6%) 0.050  0.104
History of taking medications
In the last 2 weeks 140 (14.7%) 6 (8.6%) 140 (4.3%) 0.013  0.075 0.161
More than 2 weeks 810 (85.3) 64 (91.4%) 810 (7.9%) 0.059  0.098
Hygiene practice
Washing vegetables and fruits 920 (96.8%) 66 (94.3%) 920 (7.2%) 0.055  0.088 0.204
Eating raw unwashed vegetables and fruits 30 (3.2%) 4 (5.7%) 30 (13.3%) 0.029  0.263
Table I
Statistical analysis of the risk factors associated with microscopic positives for Entamoeba species and PCR positives
for E. histolytica in asymptomatic subjects.
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infection was detected in females (9.6%) than in males 
(5.5%). Significantly higher (p < 0.05) rates were also 
recorded in low-income participants (11%) than in 
moderate-income individuals (5.2%).
Nested PCR analysis. DNA was extracted from the 
70 positive stool samples; their concentrations ranged 
from 5 µg/ml to 217 µg/ml, and purity ranged from 
2.2–2.8, as measured by a nanospectrophotometer. 
Nested PCR results indicated that 57 samples tested 
positive for the 439 bp band for E. histolytica (Fig. 1), 
which is equivalent to 81.4% of the positive samples 
and 6% of the total number of samples (Table  II). 
However, out of 57 positives, 29 carried a single infec-
tion, and 28 carried E. histolytica in combination with 
either E. dispar or E. dispar and E. moshkovskii. E. dis­
par accounted for 4.3% of the Entamoeba infections 
in the Erbil population (41 positives or 58.6% of the 
70  positive samples, as revealed by the 174 bp band 
in the microscopic analysis (Fig. 2). Of samples test-
ing positive for E. dispar, 13 carried E. dispar only, and 
28 carried mixed infections with either E. histolytica 
or E. moshkovskii. Only three samples (4.3%) tested 
positive for the 553 bp band for E. moshkovskii (Fig. 3) 
as determined by microscopy, which indicated a 0.3% 
prevalence in Erbil City; all were mixed infections. The 
negative PCR results for E. histolytica (13 samples) rep-
resented 18.6% of the positive results for E. dispar as 
a  single infection. However, the mixed infection rate 
for E. dispar with E. histolytica was 40% of the positive 
samples as determined by microscopy.
Overall PCR results showed that, out of 70 posi-
tive samples, 25 (35.7%) carried mixed infection with 
both E. histolytica and E. dispar; 3 (4.3%) samples car-
ried mixed infections with E. histolytica, E. dispar, and 
E. moshkovskii; 29 (41.4%) samples carried a  single 
infection with E. histolytica; 13 (18.6%) samples car-
ried a single infection with E. dispar, and none carried 
a single infection with E. moshkovskii.
Sequencing analysis of PCR products. The 
BLAST sequence analysis tool (NCBI) showed that the 
sequence of E. histolytica amplicon under accession 
number MT250837 was 99.7% identical to the avail-
able E. histolytica GenBank sequence, accession number 
KY884295.1.1. In comparison, E. dispar under acces-
sion number MT250839 sequence was 100% identical 
to the E. dispar GenBank sequence, accession number 
KP722600.1 and the E. moshkovskii under accession 
number sequence MT250838 showed 100% homology 
to the sequence of E. moshkovskii GenBank, accession 
number KY823428.1.
Discussion
Determining prevalence rates for E. histolytica in 
endemic regions using molecular techniques is a radi-
cal solution to light microscopy’s shortcomings (Haque 
et al. 1998; Tanyuksel and Petri 2003). For the first time 
in Erbil City lying in the north of Iraq, molecular meth-
ods were used to estimate the prevalence rates of the 
pathogenic E. histolytica, and nonpathogenic E. dispar 
and E. moshkovskii in asymptomatic populations.
The results of the present study, as determined by 
microscopic examination, showed that 7.4% of individu-
als residing in Erbil province are asymptomatic carri-
ers of at least one Entamoeba species. Several previous 
studies have recorded the prevalence rate of Entamoeba 
in Erbil City using microscopy. For example, in a study 
that included 500 diarrheal stool samples from infants 
and children, Entamoeba infections were found in 35% 
of samples (Al-Sorchee et al. 2013). In another study, the 
infection rate was 51.7%, but this study did not exclude 
the commensal protozoa Entamoeba coli (Hamad and 
Ahmed 2011). Unlike the present study, all research that 
has previously been done in Erbil City was based on 
samples from symptomatic subjects only, and this may 
be a reason for the differences in the rate of infections. 
Additionally, polymorphic leukocytes and macrophages 
in diarrheal stool samples could be misidentified as 
Entamoeba species and results in false positives.
Table II
Frequency and percentages of positive and negative results for E. histolytica, E. dispar and E. moshkovskii as single
and mixed infections.
E. histolytica 57 /70 (81.4%) 13/70 (18.6%) 57/950 (6%) 29/57 (50.9%) 28/57 (49.1%) 29/70 (41.4%) 28/70 (40%)
E. dispar 41/70 (58.6%) 29/70 (41.4%) 41/950 (4.3%) 13/41 (31.7%) 28/41 (68.3%) 13/70 (18.6%) 28/70 (40%)
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Statistical analysis of the present study showed a sig-
nificant difference (p < 0.05) in infection by Entamoeba 
species between males and females, revealing a higher 
rate of infection in females than in males. Similar 
results were reported in rural Malaysian communities 
(Ngui et al. 2012). Furthermore, significantly (p < 0.05) 
higher rates of infections were detected in low-income 
people, who often reside in poor living conditions 
and have a lower quality of life. These results are con-
sistent with research reported in northeastern India 
(Nath et al. 2015).
Nested PCR revealed that E. histolytica infection 
was the most common (6%), followed by infection with 
E. dispar (4.3%), and E. moshkovskii, which had the low-
est infection rate (0.3%) within the Erbil population. 
These results indicate that around 6% of individuals 
living in endemic regions are at risk of acquiring an 
asymptomatic infection caused by pathogenic amoeba. 
Asymptomatic carriers of E. histolytica play a significant 
role in spreading the parasite, and a prolonged asymp-
tomatic infection can lead to invasive amoebiasis and 
amoebic liver abscesses (Fotedar et al. 2007a).
Previously, there have only been four molecular-
based studies that have reported the prevalence of 
E. histolytica in Iraq. Only one study targeted non-
pathogenic E. dispar and E. moshkovskii. The stud-
ies that detected E. histolytica by molecular methods 
were conducted in Diwanyha (south-central), Baghdad 
(central), and Al-Najaf (southwest of Iraq) provinces. 
Reported prevalence rates were 44.3%, 7%, and 24%, 
respectively, among symptomatic patients (Al-Hameed-
awi 2014; Hussein et al. 2015; Al-Khalidi 2016). The 
high rates of infections reported in Diwanyha and 
Al-Najaf cities, which share internal boundaries, could 
be due to the small sample sizes of their respective stud-
ies, the differences in the study design (they studied 
the symptomatic population whereas the present work 
studied the asymptomatic population), the differences 
in environmental conditions and hygienic practices 
in these regions, and the higher population density in 
Al Najaf city (whose shrine receives thousands of visi-
tors). Amoebiasis is regarded as one of the primary 
food and water-borne diseases; the high rates of infec-
tions could be attributed to poor nutrition and sanita-
tion and contaminated water supply (Jackson 2000). 
It has been documented that about 0.5 million tons of 
sewage a day are dumped into Iraqi rivers, resulting in 
water supply contamination. This especially concerns 
southern cities that use the rivers as their primary water 
sources (Korzeniewski 2006).
The prevalence rate of the pathogenic E. histoly­
tica is higher than the non-pathogenic E. dispar and 
E. moshkovskii in the present study. Similar results 
were reported in asymptomatic individuals in Yemen, 
Mexico, and Japan (Tachibana et al. 2000; Ramos et al. 
2005; Al-Areeqi et al. 2017); the latter two studies did 
not estimate the rate of E. moshkovskii infection. Simi-
larly, the prevalence rate of E. histolytica was higher 
than the infection rate with nonpathogenic species in 
symptomatic subjects in the United Arab Emirates, 
Malaysia, and northeast India. Additionally, the stud-
ies conducted in populations living in south-west Iran, 
Cairo, Gaza Strip, and Barcelona did not determine the 
rate of E. moshkovskii infection (Al-Hindi et al. 2005; 
Pestehchian et al. 2011; Ngui et al. 2012; Rodulfo et al. 
2012; Anuar et al. 2013; Elbakri et al. 2013; Nath et al. 
2015; Roshdy et al. 2017).
The only study which discriminated among the 
three species of Entamoeba in Iraq was conducted by 
D’asheesh (2016) in Diwanyha city, south-central Iraq; 
the study involved symptomatic diarrheal patients. 
D’asheesh’s results differed from the present study 
by reporting the higher prevalence rates of E. dispar 
than E. histolytica. Similar results were recorded in 
the central and north-west regions and the Kurdistan 
province of Iran; Izmir, Turkey; Australia; and north- 
-west Ethiopia (Dagci et al. 2007; Fotedar et al. 2007b; 
Mojarad et al. 2010; Fallah et al. 2014; Yimer et al. 2017; 
Bahrami et al. 2019).
The present study reported the lowest rate of infec-
tions by E. moshkovskii; similar results were docu-
mented in western Iran, northeast India, Malaysia, 
Diwanyha, and south-central Iraq (Ngui et al. 2012; 
Nath et al. 2015; D’asheesh 2016; Bahrami et al. 2019).
In conclusion, the current study finds that 7.4% 
of individuals who live in Erbil City, where amoeba 
infections are endemic, carry intestinal Entamoeba spe-
cies, asymptomatically. The incidence rate of E. histo­
lytica was higher than the incidence rate of E. dispar 
or E. moshkovskii among asymptomatic carriers. In 
the present study, E. histolytica and E. dispar were 
reported as single or mixed infections; only three cases 
of E. moshkovskii were documented as mixed infections 
with both E. histolytica and E. dispar.
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